Stocklytics Platform
Asset logo for symbol PTCT
PTC Therapeutics
PTCT61
$36.43arrow_drop_up1.05%$0.38
Asset logo for symbol PTCT
PTCT61

$36.43

arrow_drop_up1.05%

Income Statement (PTCT)

itemJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
EBIT-$33.35M-$45.55M$3.12M-$182.70M-$119.16M
EBITDA-$26.33M$9.84M$83.82M-$118.16M-$68.15M
gross Profit$168.31M$143.84M$200.76M$187.08M$201.07M
NET Income-$99.17M-$91.57M-$155.79M-$132.97M-$198.88M
total Revenue$186.70M$210.11M$307.05M$196.57M$213.80M

Balance Sheet (PTCT)

itemJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
cash Equivalents-----
net Debt-$259.27M-$126.91M-$178.97M$539.19M$494.28M
stockholders Equity-$980.18M-$893.91M-$818.55M-$670.81M-$579.26M
total Assets$1.91B$1.78B$1.90B$1.25B$1.33B
total Debt$395.50M$421.44M$415.02M$704.35M$702.68M
total Liabilities$2.89B$2.68B$2.72B$1.93B$1.91B

Cash Flow (PTCT)

itemJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
financing Cash Flow$246.48M$540.00K$620.48M$3.36M$18.46M
free Cash Flow-$64.07M$6.41M-$128.75M-$43.72M-$33.40M
investing Cash Flow-----$23.75M
operating Cash Flow-$71.45M$70.76M-$100.28M-$14.51M-$14.12M

PTC Therapeutics (PTCT) Financials

The income statement of PTC Therapeutics Inc (PTCT) provides a detailed overview of the company's financial performance. It showcases the revenue, expenses, and profitability of the company during a specific period. The income statement helps investors and analysts assess the company's ability to generate profits and manage expenses effectively. It consists of various components such as gross profit, operating income (EBIT), net income, and earnings per share (EPS).
Gross profit represents the revenue generated from the sale of goods and services minus the cost of goods sold. It indicates the profitability of the company's core operations. EBIT (earnings before interest and taxes) represents the company's operating income before deducting interest and taxes. It helps assess the company's profitability from its core operations, excluding the impact of financing and taxes.
EBITDA (earnings before interest, taxes, depreciation, and amortization) provides a more comprehensive view of the company's profitability. It adds back non-cash expenses like depreciation and amortization to EBIT, giving a clearer picture of the company's cash flow generation capacity. Net income from stockholders represents the profit available to the company's common stockholders after deducting all expenses and taxes. It indicates the company's overall profitability. Total revenue represents the sum of all revenues generated by the company from its various sources. It reflects the company's overall sales performance. The balance sheet of PTC Therapeutics Inc (PTCT) provides a snapshot of the company's financial position at a specific point in time. It consists of various components such as assets, liabilities, and stockholders' equity.
Cash equivalents represent highly liquid assets that can be readily converted into cash. Net debt is the company's total debt minus its cash and cash equivalents. Stockholders' equity represents the residual interest in the assets of the company after deducting liabilities. It shows the book value of the company as seen by the shareholders. Total assets represent the company's total resources, including cash, investments, property, and equipment. Total debt represents the company's outstanding debt obligations, including short-term and long-term debt. Total liabilities represent the company's total obligations that need to be settled in the future. Cash flow refers to the flow of cash in and out of the company during a specific period. It helps analyze the company's liquidity, solvency, and overall financial health.
Financing cash flow represents the cash flow from financing activities, such as issuing or repurchasing equity or debt. Free cash flow is the cash flow available to the company after deducting capital expenditures necessary for maintaining or expanding its asset base. Investing cash flow represents the cash flow from investing activities, such as buying or selling assets. Operating cash flow represents the cash flow generated from the company's core operations, excluding investments and financing activities. This JSON provides a concise summary of the financial aspects of PTC Therapeutics Inc (PTCT) without resorting to any exploration or obtaining verbs.
add PTC Therapeutics  to watchlist

Keep an eye on PTC Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media